| Anna Eudora Louthan, AUD | |
|
600 Gresham Dr Ste 1100, Norfolk, VA 23507-1904 | |
| (757) 388-6200 | |
| (757) 388-6201 |
| Full Name | Anna Eudora Louthan |
|---|---|
| Gender | Female |
| Speciality | Qualified Audiologist |
| Experience | 5 Years |
| Location | 600 Gresham Dr Ste 1100, Norfolk, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386206324 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 2201001743 (Virginia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Evms Academic Physicians And Surgeons Health Services Foundation | 5698675510 | 187 |
News Archive
The nano-experts from the Center for Applied Nanotechnology (CAN) GmbH expand their product portfolio by CANdots® Series G - His Detect, which is a ready-to-use reagent for the detection of poly-histidine tagged proteins in Blot assays. It is easy to handle, highly sensitive as well as time saving compared to standard methods available on the market, e.g. ECL.
House Democrats are enjoying a feeling of momentum on health care, despite divisions within their own party, and rigid partisan battle lines. Rep. Henry Waxman, D-Calif., the chairman of the Energy and Commerce Committee, told The Hill, "I'm encouraged that we're as far along as we have come and I think we're going to make it." Another senior lawmaker said House Speaker Nancy Pelosi "has held dozens of meetings to assuage the concerns of liberal and centrist Democratic colleagues" (Bolton and Young, 10/8).
Usher syndrome (USH) is characterized by hearing loss or deafness at birth and progressive vision loss, and is the most common cause of inherited dual sensory deficit. No treatment is currently available to stop or slow the progression of vision or hearing loss in USH3, one of three clinical classifications for USH that are further divided into subtypes and all associated with different genes.
Merus Labs International Inc. is pleased to announce that their wholly owned subsidiary, Merus Labs Inc. announces the execution of a definitive agreement with Innocoll Pharmaceuticals Limited to license in, on an exclusive basis, 3 advanced wound care products for the Canadian market. Furthermore, Innocoll agrees to grant to Merus a right of first refusal for all current pipeline advanced wound care products for the Canadian Market.
› Verified 1 days ago
| Provider Name | Evms Academic Physicians And Surgeons Health Services Foundation |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1003887118 PECOS PAC ID: 5698675510 Enrollment ID: O20040304001377 |
News Archive
The nano-experts from the Center for Applied Nanotechnology (CAN) GmbH expand their product portfolio by CANdots® Series G - His Detect, which is a ready-to-use reagent for the detection of poly-histidine tagged proteins in Blot assays. It is easy to handle, highly sensitive as well as time saving compared to standard methods available on the market, e.g. ECL.
House Democrats are enjoying a feeling of momentum on health care, despite divisions within their own party, and rigid partisan battle lines. Rep. Henry Waxman, D-Calif., the chairman of the Energy and Commerce Committee, told The Hill, "I'm encouraged that we're as far along as we have come and I think we're going to make it." Another senior lawmaker said House Speaker Nancy Pelosi "has held dozens of meetings to assuage the concerns of liberal and centrist Democratic colleagues" (Bolton and Young, 10/8).
Usher syndrome (USH) is characterized by hearing loss or deafness at birth and progressive vision loss, and is the most common cause of inherited dual sensory deficit. No treatment is currently available to stop or slow the progression of vision or hearing loss in USH3, one of three clinical classifications for USH that are further divided into subtypes and all associated with different genes.
Merus Labs International Inc. is pleased to announce that their wholly owned subsidiary, Merus Labs Inc. announces the execution of a definitive agreement with Innocoll Pharmaceuticals Limited to license in, on an exclusive basis, 3 advanced wound care products for the Canadian market. Furthermore, Innocoll agrees to grant to Merus a right of first refusal for all current pipeline advanced wound care products for the Canadian Market.
› Verified 1 days ago
| Provider Name | Childrens Specialty Group Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1255354130 PECOS PAC ID: 5890788764 Enrollment ID: O20040406001195 |
News Archive
The nano-experts from the Center for Applied Nanotechnology (CAN) GmbH expand their product portfolio by CANdots® Series G - His Detect, which is a ready-to-use reagent for the detection of poly-histidine tagged proteins in Blot assays. It is easy to handle, highly sensitive as well as time saving compared to standard methods available on the market, e.g. ECL.
House Democrats are enjoying a feeling of momentum on health care, despite divisions within their own party, and rigid partisan battle lines. Rep. Henry Waxman, D-Calif., the chairman of the Energy and Commerce Committee, told The Hill, "I'm encouraged that we're as far along as we have come and I think we're going to make it." Another senior lawmaker said House Speaker Nancy Pelosi "has held dozens of meetings to assuage the concerns of liberal and centrist Democratic colleagues" (Bolton and Young, 10/8).
Usher syndrome (USH) is characterized by hearing loss or deafness at birth and progressive vision loss, and is the most common cause of inherited dual sensory deficit. No treatment is currently available to stop or slow the progression of vision or hearing loss in USH3, one of three clinical classifications for USH that are further divided into subtypes and all associated with different genes.
Merus Labs International Inc. is pleased to announce that their wholly owned subsidiary, Merus Labs Inc. announces the execution of a definitive agreement with Innocoll Pharmaceuticals Limited to license in, on an exclusive basis, 3 advanced wound care products for the Canadian market. Furthermore, Innocoll agrees to grant to Merus a right of first refusal for all current pipeline advanced wound care products for the Canadian Market.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Anna Eudora Louthan, AUD Po Box 936, Norfolk, VA 23501-0936 Ph: (757) 388-6200 | Anna Eudora Louthan, AUD 600 Gresham Dr Ste 1100, Norfolk, VA 23507-1904 Ph: (757) 388-6200 |
News Archive
The nano-experts from the Center for Applied Nanotechnology (CAN) GmbH expand their product portfolio by CANdots® Series G - His Detect, which is a ready-to-use reagent for the detection of poly-histidine tagged proteins in Blot assays. It is easy to handle, highly sensitive as well as time saving compared to standard methods available on the market, e.g. ECL.
House Democrats are enjoying a feeling of momentum on health care, despite divisions within their own party, and rigid partisan battle lines. Rep. Henry Waxman, D-Calif., the chairman of the Energy and Commerce Committee, told The Hill, "I'm encouraged that we're as far along as we have come and I think we're going to make it." Another senior lawmaker said House Speaker Nancy Pelosi "has held dozens of meetings to assuage the concerns of liberal and centrist Democratic colleagues" (Bolton and Young, 10/8).
Usher syndrome (USH) is characterized by hearing loss or deafness at birth and progressive vision loss, and is the most common cause of inherited dual sensory deficit. No treatment is currently available to stop or slow the progression of vision or hearing loss in USH3, one of three clinical classifications for USH that are further divided into subtypes and all associated with different genes.
Merus Labs International Inc. is pleased to announce that their wholly owned subsidiary, Merus Labs Inc. announces the execution of a definitive agreement with Innocoll Pharmaceuticals Limited to license in, on an exclusive basis, 3 advanced wound care products for the Canadian market. Furthermore, Innocoll agrees to grant to Merus a right of first refusal for all current pipeline advanced wound care products for the Canadian Market.
› Verified 1 days ago
Rebekah Ann Crisp, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 600 Gresham Dr, Suite 1100, Norfolk, VA 23507 Phone: 757-388-6200 Fax: 757-388-6201 | |
Alexandria Frances Matz, AU.D., CCC-A Audiologist Medicare: Medicare Enrolled Practice Location: 600 Gresham Dr Ste 1100, Norfolk, VA 23507 Phone: 757-388-6200 Fax: 757-388-6201 | |
Mrs. Jennie Rebecca Desy, M.S., CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 885 Kempsville Rd Ste 221, Norfolk, VA 23502 Phone: 757-623-0526 Fax: 757-627-6471 | |
Allen Cabahug Derina, AU.D., CCC-A Audiologist Medicare: Accepting Medicare Assignments Practice Location: 600 Gresham Dr Ste 1100, Norfolk, VA 23507 Phone: 757-388-6200 Fax: 757-388-6201 | |
Melissa G Pola, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 600 Gresham Dr, Suite 1100, Norfolk, VA 23507 Phone: 757-388-6200 Fax: 757-388-6201 | |
Alyson Noel Mellish, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 600 Gresham Dr Ste 1100, Norfolk, VA 23507 Phone: 757-388-6200 Fax: 757-388-6201 | |
Allison Cleland, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 600 Gresham Dr, Suite 1100, Norfolk, VA 23507 Phone: 757-388-6200 Fax: 757-388-6201 |